United Therapeutics Highlights Growth in Tyvaso DPI and Major Share Buyback Amid Revenue Dip
Market Chameleon (Wed, 6-May 8:20 AM)
United Therapeutics’ Tyvaso Delivers Landmark Results in IPF—TETON-1 Study Surpasses TETON-2 in Lung Function Preservation
Market Chameleon (Mon, 30-Mar 11:07 AM)
TETON-1 Study Results Signal Major Progress for United Therapeutics, Outpacing Earlier Data and Setting Up FDA Priority Review
Market Chameleon (Mon, 30-Mar 7:52 AM)
